SPY331.76+1.70 0.52%
DIA270.94+2.53 0.94%
IXIC10,980.42+39.25 0.36%

Crinetics Pharmaceuticals Q3 EPS $(0.6) Down From $(0.38) YoY, Sales $505K Down From $548K YoY

Crinetics Pharmaceuticals (NASDAQ:CRNX) reported quarterly losses of $(0.6) per share. This is a 57.89 percent decrease over losses of $(0.38) per share from the same period last year. The company reported $505 thousand

Benzinga · -

Crinetics Pharmaceuticals (NASDAQ:CRNX) reported quarterly losses of $(0.6) per share. This is a 57.89 percent decrease over losses of $(0.38) per share from the same period last year. The company reported $505 thousand in sales this quarter. This is a 7.85 percent decrease over sales of $548 thousand the same period last year.